CTRI/2023/07/055363尚未招募4 期
Assessment of Pharmacokinetic Interaction & Clinical Efficacy of Clopidogrel Coadministered with Ilaprazole
SRM College of Pharmacy SRM Institute of Science and Technology0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Healthy male volunteers of 18 to 45 years (both years inclusive) and body weight > 50 kg.
- •Willing to give informed written consent and comply with the study requirements.
- •Subject should be able to communicate effectively.
- •Non-smokers or individuals who smoke less than 5 cigarettes per day
- •Teetotalers or individuals who drink less than 60 ml of high-alcohol-content liquor or 120 ml
- •of low-alcohol-content liquor
- •Body Mass Index (BMI) between 18.50 and 24.99 Kg/m2
- •Healthy individuals as evaluated by personal history, medical history and general clinical
- •examination.
- •Vital parameters - BP should be within the range of 100 â?? 139 mmHg systolic and 60 â?? 89
- •mmHg diastolic. Pulse rate should be within the range of 60 â?? 100 / min. Temperature between
- •97.8Ë? F and 99.0 Ë? F. Respiratory rate should be within the range of 14-18/min.
- •Normal biochemical, hematological (including coagulation profile) and urinary parameters.
- •ï?· Normal Chest X-ray PA view & ECG in 12 leads.
- •Negative for HIV 1, Hepatitis B, Hepatitis C and Syphilis tests.
- •Negative urine test for drugs of abuse for morphine, barbiturates, benzodiazepines,
- •amphetamine, cocaine (to be performed on the day of check-in).
- •Negative alcohol breath analysis (to be performed on the day of check-in).
排除标准
- •Subjects incapable of understanding the informed consent
- •History of any major surgical procedure in the past 3 months
- •History of diabetes mellitus, tuberculosis and systemic hypertension
- •History suggestive of cardiac, gastrointestinal, respiratory, hepatic, renal, endocrine,
- •neurological, metabolic, psychiatric or hematological systems, judged to be clinically
- •significant.
- •History of dysphagia.
- •History of any medical disorder that is of significance in the investigatorâ??s opinion.
- •Present or past history of drug abuse.
- •History of hypersensitivity to study formulation
- •History of allergy to vegetables and/or food substances and/or any other manifestations
- •suggestive of hypersensitivity reaction
- •Present or past history of intake of drugs which potentially modify kinetics or dynamics of study
- •medication or any other medication judged to be clinically significant by the
- •investigator
- •Consumption of grapefruit / its products within 48 hours prior to the start of the study.
研究者
相似试验
已完成
不适用
Clinical Pharmacokinetic drug interaction potential of Maha yogaraja Gugglu Tablet(MYG) Tablet in Adult, Healthy, Human volunteersCTRI/2021/01/030805SRM INSTITUTE OF SCIENCE AND TECHNOLOGY
已完成
2 期
An open-label, phase 2, single centre, randomised, crossover study of two doses of Androfeme in healthy postmenopausal womedetermination of blood testosterone levels using two doses of Androfem cream in postmenopausal womenReproductive Health and Childbirth - Other reproductive health and childbirth disordersACTRN12612001250820Monash University8
已完成
不适用
DRUG INTERACTION POTENTIAL BETWEEN trans-RESVERATROL AND SIMVASTATICTRI/2023/02/049518SRM COLLEGE OF PHARMACY , SRM INSTITUTE OF SCIENCE AND TECHNOLOGY20
已完成
不适用
Assessment of pharmacokinetics and pharmacokinetic drug-drug interaction with ketoconazole of the metabolite S 41015 after single oral unlabelled microdoses of S 41015 and i.v. radiolabelled microdoses of [14C]-S 41015, and pharmacokinetics of S 38844 after single oral unlabelled microdose of S 38844 and i.v. radiolabelled microdose of [14C]-S 38844 in healthy male participantshart- en vaatziektencardiovascular diseasesNL-OMON38625Institut de Recherches Internationales Servier I.R.I.S6
已完成
1 期
Interactions between herbal medicines and the anticoagulant warfariDrug interactions of warfarin with herbal medicines in healthy male subjects. Relevant to Stroke prevention and people receiving warfarinStroke -Other -ACTRN12607000054415Prof Andrew McLachlan60
